Catalyst Wire Dossier Catalyst Wire Dossier

Berinert

C1 esterase inhibitor · CSL Behring
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Berinert, covering 2010-08-24 to 2023-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema [Phase 3]

See pricing